InfiMotion Inside: Industry-Leading E-Drive Systems Power Multiple Brands at the Paris Motor Show

PARIS, Oct. 19, 2026 /PRNewswire/ -- The 2026 Paris Motor Show runs October 12 to 18 at the Paris Porte de Versailles Exhibition Center. InfiMotion Technology, a core force in China's powertrain sector, does not exhibit independently — yet its electric drive systems appear across multiple automaker lineups, including nearly every vehicle on the Geely Auto stand, plus Lynk & Co, Zeekr, and Smart models. The Geely stand also hosts the European debut of the Monjaro EM-i alongside the EX2, EX5, and STARRAY EM-i. InfiMotion's newest products also appear at Geely's UTAC roadshow in France, giving European media direct access to its next-generation e-drive portfolio.

Technological Leadership: Setting Global Benchmarks

InfiMotion's new off-road dual-motor e-drive — the only locking dual-motor system in its class — debuts on the Geely K011, delivering 220 kW per motor and combined peak torque of 2 x 4,500 N•m. Its differential-lock controller stacks output onto one side to free a stuck vehicle; per-wheel distribution reaches 9,000 N•m at one wheel, a 200% amplification. It is IPX8-rated, having passed iceberg impact and submersion tests.

The portfolio spans 400V to 900V. The TP501 900V co-axial dual motor drive uses a semi-solid die-cast magnesium alloy housing, cutting weight by 30%. The P600 Compact EDU, above 750V, achieves 92.4% CLTC efficiency through Mini-Pin winding and 0.2 mm ultra-thin silicon steel. Proprietary deep oil-cooling enables over 100 consecutive full-throttle accelerations without degradation. The off-road system is already in series production, and the 11-in-1 domain-controlled EDU launched in 2024 powers the Geely Galaxy E5, China's top-exporting A-segment electric SUV.

Global Competitiveness: A Growing International Footprint

In H1 2026, InfiMotion ranked among China's top three suppliers by shipment for electric motors and inverters. Its R&D network spans Wuxi, Shanghai, Ningbo, Hangzhou, and Gothenburg, with 1,000+ engineers including 100+ Swedish software specialists. Five smart manufacturing bases in China support a global supply footprint reaching Europe and Malaysia. Its CNAS-certified testing center houses the world's first 30,000 rpm motor test bench, with validation spanning -60°C to 140°C thermal cycling, 1,500-hour salt spray, and 2,500-hour endurance runs.

About InfiMotion Technology

InfiMotion Technology is a global innovator in intelligent e-drive systems, providing full-spectrum green smart mobility solutions. Core products include electric drive systems, domain controllers, charging systems, and battery management systems. Serving leading automakers worldwide, it delivers proven, traceable, mass-produced e-drive solutions from A0-class vehicles to supercars.

Share this article

Lazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure

LONDON, Oct. 19, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today announced the appointment of David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure.

David brings over two decades of consumer-focused M&A advisory experience, with a particular focus on food and beverage, home and personal care, and select consumer health categories. He joins Lazard from J.P. Morgan, where he served as Managing Director and Co-Head of Consumer & Retail EMEA. Previously, he held senior roles at Credit Suisse, Centerview Partners, and UBS. David holds an honors degree from the European Business School London and is fluent in German and Spanish.

Based in London, David will join Lazard's financial advisory practice for Europe, led by Jean-Louis Girodolle and Cyrus Kapadia. His appointment underscores Lazard's continued investment in senior talent as part of its Lazard 2030 strategy, which includes a commitment to growing the firm's Managing Director ranks across its advisory franchise.

"David is a highly regarded advisor with an exceptional track record of helping boards and management teams navigate complex strategic inflection points and transformative transactions. We are delighted to welcome him to Lazard," said Jean-Louis Girodolle, Co-Head of European Investment Banking.

"David is a trusted counselor to many of the sector's leading businesses, and his deep expertise and longstanding relationships will further strengthen our franchise as we continue to invest in our European platform and enhance our capabilities for clients," said Cyrus Kapadia, Co-Head of European Investment Banking.

"I have long admired Lazard's advisory-led, partnership-oriented model and the strength of its presence and connectivity across Europe and North America. I am a firm believer in the ambitions of the Lazard 2030 strategy and the growth the firm is working to achieve. I look forward to joining Lazard's talented team helping to shape and scale its global consumer franchise," said David Krap.

About Lazard

Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Lazard is listed on the New York Stock Exchange as Lazard, Inc. under the ticker LAZ. For more information, please visit Lazard.com and follow Lazard on LinkedIn.

Media Relations

Poppy Trowbridge, +44 20 7187 2065

[email protected]

Flore Larger, +33 6 33 13 41 50

[email protected]

Share this article

The learning leader behind development programs for one of the world's largest professional services firms will help Yoodli customers turn practice into skills people actually use on the job

SEATTLE, Oct. 19, 2026 /PRNewswire/ -- Yoodli, the AI Platform for Human Skills, today announced that Mike Mather, former Chief Learning Officer at KPMG, has joined the company as Chief Learning Advisor. In the role, Mather will work directly with Yoodli customers and the product team to shape how organizations enable their workforce for the AI future.

As Chief Learning Officer of KPMG US from 2023 to September 2026, Mather led the firm's work to prepare its workforce for the AI and digital age. In 2023, KPMG was named Chief Learning Officer magazine's LearningElite Organization of the Year. Before that, he led KPMG's Workforce Transformation and Development practice and spent more than two decades as a partner at EY, IBM and PwC, advising Fortune 100 organizations on HR and learning transformation. He is a Chartered Accountant (Canada) and holds an MBA.

At Yoodli, he will advise customers on building readiness programs that move beyond course completions to measurable behavior change. Yoodli is already used by some of the world's largest sales enablement and learning teams, including Google, Databricks, FranklinCovey, Korn Ferry and Snowflake, for AI tool training, manager coaching and go-to-market enablement. He will also bring the CLO's perspective into Yoodli's product roadmap as the company builds out its AI Platform for Human Skills, pairing realistic AI-powered practice with coaching and measurement so new skills get applied on the job, not just learned.

"Learning leaders don't need another place to send people. They need proof that their people are ready," said Varun Puri, co-founder and CEO of Yoodli. "Mike has run learning at a scale few people ever see, and he knows exactly what CLOs are measured on. He'll help our customers get to real outcomes faster."

"For most of my career, the hardest part of L&D was the gap between training and the moment someone actually has to perform," said Mike Mather, Chief Learning Advisor at Yoodli. "Yoodli closes that gap. I'm excited to help learning teams use it to show the business what readiness really looks like."

About Yoodli

Yoodli is the AI Platform for Human Skills. Through AI coaching, learning journey creation, roleplays, personas, and measurement, Yoodli helps people get measurably better in their careers and helps organizations upskill their workforce for an AI-first world. Proven in high-stakes revenue teams and built for company-wide scale, Yoodli is used by organizations including Google, Snowflake, and Databricks. Learn more at yoodli.ai.

Media Contact:

Sage Quiamno

[email protected]

+1 (808) 232-1321

SOURCE Yoodli

Share this article

TraceLink Expands Global Investment in Track & Trace and Supply Chain Agentic Business Processes

Dedicated Commercial, R&D, and Services organizations accelerate innovation, customer success, and agentic transformation across both commercial business lines

BOSTON, Oct. 19, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced a major organizational investment, establishing dedicated global Commercial, Research & Development (R&D), and Services teams for its Track & Trace Compliance and Supply Chain Agentic Business Process (ABP) businesses.

The evolved operating model provides each business with specialized expertise spanning product innovation, customer engagement and education, implementation, and ongoing success. The investment reinforces TraceLink's long-term commitment to its Track & Trace customers worldwide while accelerating the development and adoption of Agentic Business Processes across both commercial business lines.

Doubling Down on Track & Trace Customer Success and Innovation

TraceLink is expanding its commitment to Track & Trace customers through a new dedicated Customer Account Management organization, continued global compliance innovation, and the rapid introduction of Track & Trace Agentic Business Processes.

Dedicated Customer Account Managers will help organizations that partner with TraceLink maximize the value of their existing investments, improve operational and compliance outcomes, and navigate evolving regulatory requirements. TraceLink continues to advance its multinational compliance roadmap, including emerging requirements in Egypt and Ethiopia, the FDA's transition to a uniform 12-digit National Drug Code, and regulatory developments across other markets.

At the same time, TraceLink is accelerating the introduction of Track & Trace ABPs that combine governed OPUS Agents with serialization, traceability, compliance, and supply network information. These advancements will help customers automate compliance reporting, manage exceptions and recalls, improve productivity, and progressively agentify their Track & Trace operations.

Scaling Supply Chain Agentic Business Processes

Growing adoption of TraceLink's MINT, POET, and groundbreaking OPUS Agents solutions has enabled the company to establish a dedicated global commercialization organization for Supply Chain ABPs.

Specialized Sales Executives, Agentic Business Process Architects, Value Engineers, and supporting teams will work with customers to identify high-value opportunities, establish business cases, and deploy Agentic Business Processes that digitalize and agentify complex supply chain operations across planning, procurement, manufacturing, inventory, logistics, and commerce.

These resources will help customers accelerate their transformation journeys and achieve measurable improvements in productivity, service, cost, working capital, and operational performance.

Dedicated Expertise Across Two Business Lines. One TraceLink Platform.

"We are making major investments for our customers with enormous opportunities ahead," said Shabbir Dahod, President and CEO of TraceLink. "By aligning our Commercial, R&D, and Services organizations around each business, we are strengthening our commitment to existing customers while accelerating transformation and growth. Agentic Business Processes are central to the future of both Track & Trace and Supply Chain operations. We intend to create synergistic value for all end-to-end supply chain processes."

Both business lines operate on TraceLink's OPUS Platform and Integrate-Once™ Agentic Business Network, enabling customers to build on existing digital foundations as they adopt new Agentic Business Processes. Track & Trace Compliance intersects and integrates with all end-to-end supply chain operations. With the single Agentic OPUS Platform, customers can integrate business transactions and information, with agents working across all processes.

Customers benefit from dedicated expertise across each business, coordinated account engagement, and the full support of TraceLink's global services, technical support, education resources, and partner ecosystem.

Learn More at FutureLink Barcelona

Explore TraceLink's latest Track & Trace capabilities, emerging Track & Trace ABPs, and Supply Chain Agentic Business Processes at FutureLink Barcelona, October 19–21, 2026.

About TraceLink

TraceLink powers the transformation to an Agentic Supply Chain Operating Model, enabling organizations to perform and improve supply chain work across their business and trading partner networks. The OPUS Agentic Supply Chain Operating System brings together Agentic Business Processes, Agentic Control Towers, governed OPUS Agents, and the Integrate-Once™ Agentic Business Network to link systems, end-to-end business transactions, and collaborative peer-to-peer processes with trusted, real-time operational context. In this agentic environment, humans and agents work together with greater speed, reasoning, control, and accountability to improve organizational productivity, service, inventory, working capital, cost, compliance, quality, resilience, and revenue performance.

Learn more at www.tracelink.com.

SOURCE TraceLink, Inc.

Share this article

As part of TECNO and artist Angélica Dass's global "100 Portraits of Becoming" project, the new BBC StoryWorks film reveals the personal journeys behind the portraits, bringing to life a shared vision of seeing beyond the image to understand the people behind it.

HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Global innovative technology brand TECNO has jointly produced and released a new film with BBC StoryWorks to unveil the project of "100 Portraits of Becoming," a two-year global portrait project co-created by TECNO and internationally acclaimed visual artist Angélica Dass which started from Kenya as the first chapter. Building on TECNO's philosophy of inclusive imaging technology and Angélica Dass's distinctive approach to portraiture, the project plans to bring together 100 portraits and personal stories across five countries, moving beyond visual representation to explore the individuality and humanity behind each portrait. Through the personal journeys featured in the film, audiences gain a glimpse into the energy and aspirations of people navigating today's changing world — how they are finding their own paths, shaping new possibilities and imagining who they want to become.

The film also explores the shared vision behind TECNO's collaboration with Dass. While TECNO's Universal Tone technology seeks to fairly represent the beauty of different skin tones and human diversity, Dass's work has long challenged the labels and assumptions through which we see others. Together, they bring a shared belief to "100 Portraits of Becoming": that being seen is about more than appearance — it is also about being understood for who we are.

Through the film, this idea comes to life in Kenya, where the first chapter of "100 Portraits of Becoming" began. It introduces some of the people behind the portraits, each with a different story of finding their own way forward. For agripreneur Alex Mutua Muli, opportunity wasn't something to seek elsewhere, but something to create at home. By connecting local farmers to wider markets, he is helping build a future in the community where he grew up. Alexander Odhiambo took a different path, turning an uncertain start to his career into a new beginning. From a small apartment in Nairobi, he co-founded a software company that has since grown to serve markets across Africa, opening doors for others along the way. And for Jelimo Cheboi, what began as a small WhatsApp group became something much bigger. As co-founder of GirlSkate Nairobi, she has helped turn a shared passion for skateboarding into a growing community where girls and women can challenge expectations, find belonging, and express themselves on their own terms.

Their stories are different, but each challenges an assumption about what is possible — whether it is where opportunity can be found, what a career can become, or who gets to belong. Together, they offer a glimpse of the people behind the portraits, whose lives cannot be summed up by a single image or label.

"The beauty of this project was the chance to look beyond an image and let people tell their own stories. Through their passions and experiences, every person we met brought a vibrancy and depth to the film that a single portrait may not fully capture. We hope the film will encourage audiences to see people with a little more curiosity and a little more understanding," said Tom Deakin, Director, Content Strategy at BBC StoryWorks APAC.

"100 Portraits of Becoming" is a two-year global project bringing together 100 portraits and personal stories across Kenya, the Philippines, Saudi Arabia, Türkiye and Brazil. Together, these portraits and stories will form a growing collection that celebrates the many different ways of being human — 100 people, 100 stories and 100 ways to see humanity. Following its first chapter in Kenya, the project will continue its journey to more countries around the world, uncovering new stories, experiences and perspectives on what it means to become. Stay tuned for more inspiring stories and the latest updates from "100 Portraits of Becoming" on the BBC StoryWorks project page and "100 Portraits of Becoming" by TECNO and Angelica Dass official website.

About TECNO

As a global innovative technology brand with operations in over 70 markets, TECNO has been committed to revolutionizing the digital experience in global emerging markets, relentlessly pushing for the perfect integration of contemporary, aesthetic design with the latest technologies and AI. TECNO offers a wide range of smartphones, smart wearables, laptops and tablets, smart gaming, HiOS operating systems and smart home products. Guided by its brand essence of "Stop At Nothing," TECNO is committed to unlocking the newest technologies and AI-powered new experiences for forward-looking individuals, inspiring them to never stop pursuing their best selves and their best futures. For more information, please visit TECNO's official site: www.tecno-mobile.com.

About "100 Portraits of Becoming" by TECNO and Angélica Dass

"100 Portraits of Becoming" is a global portrait project created by TECNO together with internationally recognized artist Angélica Dass. Over two years, it will produce one hundred portraits across five countries — Kenya, the Philippines, Saudi Arabia, Türkiye and Brazil — pairing Dass's portrait methodology with TECNO's Universal Tone inclusive imaging technology. Each portrait moves beyond a face to the person behind it: to lives unfolding across different cultures, generations and moments of social change. One hundred portraits become one hundred ways of seeing humanity — and one growing archive of who we are, told by the people living it. To learn more, please visit: https://www.tecno-mobile.com/100portraitsofbecoming/.

SOURCE TECNO MOBILE LIMITED

Share this article

VTT Info: Finland lays the groundwork for large-scale underground hydrogen storage in crystalline bedrock

ESPOO, Finland, Oct. 19, 2026 /PRNewswire/ -- As Europe scales up renewable hydrogen production, large-scale hydrogen storage will be needed to balance production and consumption. A new Finnish study by VTT Technical Research Centre of Finland and Geological Survey of Finland GTK, together with companies operating in Finland's hydrogen economy, shows that underground hydrogen storage can also be developed in crystalline bedrock - an important finding for countries and regions that cannot rely on salt caverns.

Underground hydrogen storage is needed to balance hydrogen production and use over days and weeks, not just hours. While hydrogen transmission pipelines can provide short-term flexibility, multi-day balancing requires large underground storage facilities. The findings are particularly relevant for Finland, which aims to become one of Europe's leading hydrogen economies but lacks the underground salt caverns that are available for hydrogen storage in many other European countries.

"Developing underground hydrogen storage facilities is a lengthy and capital-intensive undertaking. The project estimated that constructing a 40,000 m³ storage facility would cost approximately EUR 30 million. Including planning and permitting phases, the overall project duration would be four to five years," says Pasi Valkokari, Senior Scientist at VTT and project leader of the research initiative.

In a joint research project funded by Business Finland, VTT and GTK have, for the first time, carried out a comprehensive assessment of the requirements for hydrogen storage under Finnish conditions. The HUG project also involved nearly twenty companies operating in Finland's hydrogen economy.

"The project has generated valuable knowledge on underground hydrogen storage alternatives and improved understanding of both the opportunities and the remaining uncertainties that need to be resolved. The results provide a strong foundation for developing large-scale hydrogen storage as an integral part of future hydrogen systems," says Satu Sipola, Vice President, Hydrogen and Power-to-X, at Fortum Power and Heat.

Storage cavern design and safety require further research

Existing underground salt caverns in Central Europe and the United Kingdom can be used for hydrogen storage as they provide naturally gas-tight conditions. Finland, however, lacks suitable salt formations, meaning that storage caverns must be excavated in crystalline bedrock and gas-tightness created with technical solutions. This makes Finland a relevant test case for other regions where salt cavern storage is not available.

"The geological site selection, site investigations, and material studies for a hard rock hydrogen storage facility are essential to ensure that the surrounding bedrock remains stable and that safety is not compromised if hydrogen were to react with other materials," says Teemu Lindqvist, Geologist at GTK.

The joint study examined the feasibility of locating large underground hydrogen storage caverns in Finnish bedrock. As an outcome, the project developed a high-level storage concept covering storage structure design, operating models, geological and safety requirements, technical and societal risks, investment needs, and ecosystem models. In addition to the findings, several important technical, commercial and regulatory questions remain and will require further investigation.

"We are now preparing the next phase of the research with the industry consortium and aim to continue developing the research-based design requirements that will enable the development of a pilot facility and a replicable storage concept for wider deployment," says Jutta Nyblom, who is responsible for industrial collaboration in the project and for preparing the initiative at VTT.

Phased development of hydrogen economy

Finland's hydrogen economy is expected to develop in stages. The first phase will see the emergence of regional hydrogen clusters. As hydrogen production and consumption volumes grow, dedicated storage facilities will become a critical enabler of commercially viable hydrogen value chains by helping to stabilise hydrogen prices and availability.

Initially, smaller storage solutions will suffice. However, the need for medium-scale underground hydrogen storage facilities with a volume of 10,000 to 40,000 cubic metres is expected to grow rapidly.

"Public investment support is critical to accelerating green hydrogen investment and the development of Finland's hydrogen economy, as well as ensuring that storage projects can move forward without delay. Alongside public support, projects will require close collaboration across value chains, a stable and predictable regulatory environment, and firm offtake commitments to move forward," says VTT's Pasi Valkokari.

Industrial partners of the HUG project 

AFRY Finland Oy

BusinessOulu

Danfoss Drives Oy

DEKRA Industrial Oy

EDR Medeso Oy

Energiateollisuus ry

Fortum Power and Heat Oy

Gasgrid vetyverkot Oy

Geomachine Oy

Green North Energy Oy

Helen Oy

Lujabetoni Oy

Mincon Nordic Oy

Neste Oyj

St1 Oy

Sweco Finland Oy

Valmet Automation Oy

Vantaan Energia Oy

The project was primarily funded by Business Finland. Research activities were carried out by VTT Technical Research Centre of Finland and the Geological Survey of Finland GTK.

CONTACT:

For additional information:

Read the full report here

Media material with pictures and infographic

HUG website

VTT

Pasi Valkokari, Senior Scientist

[email protected]

+358 40 827 8919

Jutta Nyblom, Senior Scientist for industry collaboration and HUG2 project preparation

[email protected]

+358 40 538 8430

Geological Survey of Finland GTK

Teemu Lindqvist, Project Manager

[email protected]

+358 29 503 2171

Fortum

Fortum NewsDesk, [email protected], +358 40 198 2843

Further information on VTT:

Satu Holm-Jumppanen

Manager, Communications

+358 50 305 4718, [email protected] 

www.vtt.fi

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

Share this article

HAIFA, Israel, Oct. 19, 2026 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that it was awarded a contract valued at approximately $235 million to supply EXTRA-MR (Medium Range) rockets and Precise & Universal Launching System (PULS™) rocket artillery systems to a European customer, under a government-to-government (G-to-G) agreement between the Israel Ministry of Defense and the customer country's Ministry of Defense. The contract will be performed over a period of three years.

Under the contract, Elbit Systems will supply the medium-range variant of the Company's EXTRA supersonic rocket system. The contract also includes the delivery of PULS launchers, additional rocket-artillery-related platforms, and integrated logistics support.

The EXTRA-MR (Medium-Range) is a precision-guided rocket munition designed for mid-range operational scenarios, enabling highly accurate engagement of high-value targets at ranges of up to 80 km. Fully compatible with Elbit Systems' PULS and existing C4I architectures, the system provides a flexible and cost-effective capability across a broad range of mission profiles.

Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems: "This contract award further strengthens Elbit Systems' position as a global leader in rocket artillery systems and reflects the growing international demand for our advanced rocket and launcher capabilities. The PULS systems and precision rocket solutions are recognized among the leading systems in their category and have been selected by a growing number of customers worldwide, including European and NATO member states. We remain committed to delivering advanced operational capabilities that support our customers' evolving defense requirements."

About Elbit Systems

Elbit Systems is a leading global defense technology company, delivering advanced solutions for a secure and safer world. Elbit Systems develops, manufactures, integrates and sustains a range of next-generation solutions across multiple domains.

Driven by its agile, collaborative culture, and leveraging Israel's technology ecosystem, Elbit Systems enables customers to address rapidly evolving battlefield challenges and overcome threats.

Elbit Systems employs over 21,000 people in dozens of countries across five continents. The Company reported $2,287.1 million in revenues for the three months ended June 30, 2026 and an order backlog of $32.0 billion as of such date.

For additional information, visit: https://elbitsystems.com, follow us on X or visit our official Facebook, Youtube and LinkedIn Channels.

Company Contact: 

Dr. Yaacov (Kobi) Kagan, Executive VP - CFO

Tel:  +972-77-2946663

[email protected] 

Daniella Finn, VP, Investor Relations

Tel: +972-77-2948984

[email protected]

Dalia Bodinger, VP, Communications & Brand

Tel: 972-77-2947602+

[email protected]

This press release may contain forward–looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management's current expectations, estimates, projections and assumptions about future events. Forward–looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company's future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forward–looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; including the duration and scope of the war in Israel, and the potential impact on our operations; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward–looking statements speak only as of the date of this press release.

Although the Company believes the expectations reflected in the forward-looking statements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The Company does not undertake to update its forward-looking statements.

Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this press release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies. All other brand, product, service and process names appearing are the trademarks of their respective holders. Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein.

SOURCE Elbit Systems Ltd.

Share this article

Share buybacks in Ericsson during the period October 12 - October 16, 2026

STOCKHOLM, Oct. 19, 2026 /PRNewswire/ -- During the period October 12 - October 16, 2026, Telefonaktiebolaget LM Ericsson (publ) ("Ericsson") (LEI code 549300W9JLPW15XIFM52) repurchased own Class B shares (ISIN: SE0000108656) as follows:

The share repurchases are a part of the share buyback program of up to SEK 15,000,000,000 which Ericsson announced on April 16, 2026, and which runs between April 23, 2026, and March 31, 2027, at the latest. The Board of Directors intends to propose to the 2027 Annual General Meeting that the repurchased shares, other than those used to fulfil Ericsson's obligations under its share-related incentive programs, are cancelled.

The share buyback program is executed in accordance with the Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing MAR (the Safe Harbour Regulation).

All acquisitions have been carried out on Nasdaq Stockholm by Goldman Sachs Bank Europe SE on behalf of Ericsson. A full breakdown of the transactions is attached to this announcement.

Following the repurchases above, Ericsson's holding of treasury stock amounts to 129,915,894 Class B shares. There are in total 3,371,351,735 shares in Ericsson, 261,755,983 shares of Class A and 3,109,595,752 shares of Class B.

NOTES TO EDITORS:

FOLLOW US:

MORE INFORMATION AT:

Ericsson Newsroom

[email protected]  (+46 10 719 69 92)

[email protected]  (+46 10 719 00 00)

Investors

Daniel Morris, Vice President, Head of Investor Relations

Phone: +44 7386 657217

E-mail: [email protected]

Lena Häggblom, Director, Investor Relations

Phone: +46 72 593 27 78

E-mail: [email protected]

Media

Ralf Bagner, Head of Media Relations

Phone: +46761284789

E-mail: [email protected]

ABOUT ERICSSON:

Ericsson's high-performing, programmable networks provide connectivity for billions of people every day. For 150 years, we've been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

SOURCE Ericsson

Share this article

WuXi Biologics at Festival of Biologics Basel 2026: Turning Scientific Complexity into Commercial Certainty

BASEL, Switzerland, Oct. 19, 2026 /PRNewswire/ -- More than 3,000 industry professionals gathered at Festival of Biologics Basel 2026 to exchange insights on the future of biologics. Extending this industry conversation, WuXi Biologics hosted its 3rd annual Basel CRDMO+ Day, convening more than 100 biotechnology and pharmaceutical leaders and experts to discuss a common challenge: how to develop, manufacture and deliver increasingly complex biologics faster, more reliably and with greater certainty.

As biologics pipelines expand beyond conventional monoclonal antibodies into bispecific antibodies, ADCs and other advanced modalities, innovators face a broader set of interconnected decisions across molecule design, manufacturability, scale-up and commercialization. Addressing these decisions early can help shorten timelines, reduce risk, and improve execution across the product lifecycle.

Scaling Complex Biologics with Greater Speed and Predictability

The biologics industry is entering a new phase of complexity. Bispecific antibodies, ADCs, and other advanced modalities now represent a growing share of innovation pipelines.

Supporting innovation at scale requires both capacity and execution. WuXi Biologics will expand annual capacity for approximately 300 IND programs and 20 BLA programs by 2027, supported by a portfolio of 1,064 integrated projects, including 399 first-in-class programs, 732 global IND clearances, and more than 90 market authorizations.

The shift toward complex molecules is already visible within this portfolio. Of the 169 projects added during the first half of 2026, 71% were bispecific antibodies or ADCs. More than two-thirds of these new programs originated from the United States and Europe, underscoring growing demand for increasingly sophisticated biologics.

For innovators, the value of platform innovation lies in making early development faster and more predictable. The WuXia™ TrueSite Targeted Integration platform, has been adopted in 70+ projects, delivers average clone titers of 8 g/L, near-100% clone stability and significantly improved pool-to-clone consistency. These improvements can substantially reduce downstream development risk while accelerating progression toward IND.

Speed has emerged as a critical strategic lever in biologics development. WuXi Biologics introduced its clone-derived six-month DNA-to-IND solution six years ago. Using final production clones rather than pool-derived materials, reducing future comparability risks while significantly shortening development timelines. Since its launch, the platform has been applied across 66 accelerated programs, with 6 assets advancing into late-stage and commercial manufacturing.

Identifying the Right Platform for the Right Molecule

As molecule diversity increases, selecting the right pathway and manufacturing platform has become a strategic advantage.

Rather than applying a single development model across all molecules, developers increasingly require fit-for-purpose platforms that address specific biological, manufacturability, and scale-up challenges.

To support this evolution, WuXi Biologics has expanded beyond traditional mammalian expression systems into microbial and HEK293 development platforms supporting enzymes, cytokines, antibody fragments, nanobodies, recombinant proteins, and other emerging modalities.

The microbial platform provides a strong example of this expansion. Microbial-derived biologics now represent a significant and growing portion of the biologics landscape. WuXi Biologics has accumulated experience from more than 3,000 fermentation runs across more than 140 molecules, with commercial scale-up experience reaching 15,000 liters.

Its knowledge-driven development approach has enabled:

- 30%-50% faster development timelines

- More than 95% first-time scale-up success rates

- Sequence-to-GMP drug substance release in approximately 9.5 months

- Technology transfer to BLA timelines reduced from approximately 30 months to as little as 18 months

The platform also demonstrates how process innovation drives stronger commercial economics. Across multiple programs, process optimization, scale-up strategies and raw-material improvements have generated total cost reductions of approximately 40%-50%. For developers preparing to scale, these improvements can strengthen cost competitiveness while reducing the operational burden of commercial manufacturing.

Designing for Treatment Convenience and Efficiency

For many biologics, competitive advantage is increasingly determined not only by molecular performance, but also by how therapies are designed and delivered to better meet patient needs and improve treatment convenience.

As healthcare systems push toward greater convenience and efficiency, high-concentration formulations, subcutaneous delivery and drug-device combination products are becoming critical strategic considerations much earlier in development.

WuXi Biologics has now supported:

- More than 500 formulation and drug product processes

- More than 180 high-concentration biologics programs

- More than 130 programs reaching concentrations up to 240 mg/mL

- More than 30 syringe and combination-device programs

The company's WuXiHigh™ 2.0 platform has expanded formulation screening from 8 to 24 formulations in parallel while delivering viscosity reductions of up to 90%. These capabilities support concentration that would previously have been considered impractical for routine development and manufacturing.

Innovation continues beyond conventional high-concentration formulations. New ultra-high-concentration approaches are targeting protein concentrations up to 500 mg/mL, opening opportunities for next-generation subcutaneous and intramuscular delivery.

Hyaluronidase-enabled co-formulation has emerged as another rapidly growing area, supported by more than 30 projects. These approaches can significantly reduce administration time while improving patient convenience and product competitiveness.

As biologics grow more complex and patient needs increasingly shape product design, drug product development is becoming a strategic differentiator rather than a downstream activity.

Turning Development Know-How into Commercial Success

Scientific innovation creates value only when it can be translated into consistent commercial supply.

To help clients plan for regional supply and future demand, WuXi Biologics operates a global manufacturing network exceeding 600,000 liters of planned bioreactor capacity across Ireland, Germany, Singapore, the United States, and China. Approximately half of this capacity is located outside China, supporting a resilient global supply strategy.

The company's commercial track record includes:

- A 100% PPQ campaign success rate

- More than 2,600 drug substance batches delivered with a 98.7% success rate

- More than 2,670 drug product batches delivered with a 99.6% success rate

As biologics programs advance toward commercialization, technology transfer is becoming a critical bridge between development speed and manufacturing readiness. WuXi Biologics has completed more than 220 transfer-in projects involving more than 10 host cell lines and multiple molecule classes. Accelerated programs have achieved GMP drug substance vial thaw in less than three months, with more than 10 programs completed in under two months.

WuXi Biologics' dual-sourcing strategy gives clients greater agility and resilience in global supply, providing a proven pathway to expand commercial production across sites with greater confidence. Several commercial products have successfully launched first in China and subsequently in Ireland, with PPQ completion at the second site occurring as little as one year while maintaining comparability and, in some cases, upgrading process performance and reducing cost.

Commercial process optimization remains a significant value driver. Through multiple commercial programs, manufacturing innovations have delivered:

- Up to 450% titer increases

- Up to 80% cost-of-goods reductions

- Up to 200% productivity increases through media and process improvements

The impact extends beyond manufacturing. Programs supported by WuXi Biologics have been associated with 140 acquisitions and 42 client IPOs, demonstrating how reliable execution can help clients advance critical assets and create value at pivotal stages of company growth.

Building Predictability Through Digitalization

As biologics become more complex, the ability to translate data into actionable insights is becoming critical to reducing uncertainty and improving predictability.

WuXi Biologics is integrating digital capabilities across development, manufacturing, quality and customer collaboration to improve visibility, accelerate decision-making and strengthen execution.

Digital platforms support technology transfer, manufacturing planning, deviation investigation, process monitoring and customer engagement through a connected data environment. This includes PatroLab™, a digital manufacturing platform designed to increase process visibility, reduce risk, improve scale-up consistency and strengthen commercial robustness. Rather than reacting to variability after it occurs, the platform helps teams identify process drift earlier and convert manufacturing variability into more predictable commercial performance.

This transition toward a digital-native CRDMO aims to improve execution by combining scientific expertise, manufacturing knowledge and connected data to drive more predictable and efficient execution. Ultimately, the goal is greater visibility, earlier risk identification and increased certainty across the product lifecycle.

An Integrated Model for Biologics Success

The message from WuXi Biologics CRDMO+ Day Basel 2026 was clear.

Microsoft ends support for Internet Explorer on June 16, 2022.

We recommend using one of the browsers listed below.

Please contact your browser provider for download and installation instructions.

October 19, 2026

Information is current as of the date of issue of the individual press release.

Please be advised that information may be outdated after that point.

WEB media that thinks about the future with NTT